Generation of Fas-independent CD4+cytotoxic T-cell clone specific for p190 minor bcr-abl fusion peptide

被引:6
|
作者
Tanaka, Y
Takahashi, T
Nieda, M
Masuda, S
Kashiwase, K
Takahashi, T
Ogawa, S
Chiba, S
Juji, T
Hirai, H
机构
[1] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Japanese Red Cross Cent Blood Ctr, Tokyo, Japan
关键词
Philadelphia chromosome-positive acute lymphoblastic leukemia; minor BCR/ABL; CTL;
D O I
10.1016/S0145-2126(01)00119-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the majority of Ph + ALL patients, p190 bcr-abl fusion protein is generated in the Philadelphia chromosome. The fusion protein may serve as a leukemia antigen because it is not expressed in normal cells and hardly in any other malignancy. From a healthy donor, we have established a p190 bcr-abl fusion peptide-specific CD4+ cytotoxic T-cell clone, activation of which depends on HLA-DRB1*1501. This T-cell clone has a strong cytotoxic activity against autologus MoDCs pulsed with ela2 peptide and its cytotoxicity is not mediated by Fas/Fas ligand or perforin pathway. Success in establishment of the p190 bcr-abl fusion peptide-specific T-cell clone encourages us to develop a new approach to an effective immunotherapy for Ph + ALL. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:317 / 321
页数:5
相关论文
共 49 条
  • [21] A CD4+T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells
    Zorn, E
    Orsini, E
    Wu, CJ
    Stein, B
    Chillemi, A
    Canning, C
    Alyea, EP
    Soiffer, RJ
    Ritz, J
    TRANSPLANTATION, 2001, 71 (08) : 1131 - 1137
  • [22] Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes
    M Makita
    T Azuma
    H Hamaguchi
    H Niiya
    K Kojima
    S Fujita
    M Tanimoto
    M Harada
    M Yasukawa
    Leukemia, 2002, 16 : 2400 - 2407
  • [23] Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes
    Makita, M
    Azuma, T
    Hamaguchi, H
    Niiya, H
    Kojima, K
    Fujita, S
    Tanimoto, M
    Harada, M
    Yasukawa, M
    LEUKEMIA, 2002, 16 (12) : 2400 - 2407
  • [24] Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph plus acute lymphoblastic leukaemia
    Basso, S.
    Quartuccio, G.
    Guido, I.
    Quadrelli, C.
    Gurrado, A.
    Piantoni, L.
    Zavras, N.
    Cantoni, F.
    Falcone, R.
    Riva, G.
    Barozzi, P.
    Potenza, L.
    Maccario, R.
    Zecca, M.
    Luppi, M.
    Comoli, P.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S321 - S321
  • [25] Clonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligand
    Preckel, T
    Hellwig, S
    Pflugfelder, U
    Lappin, MB
    Weltzien, HU
    IMMUNOLOGY, 2001, 102 (01) : 8 - 14
  • [26] Rapid generation of quadrivirus-specific CD8+and CD4+cytotoxic T-lymphocytes (CTLs) for adoptive transfer after stem cell transplantation (SCT)
    Spyridonidis, A.
    Muranski, P.
    Kerkar, S.
    Tanimoto, K.
    Hensel, N.
    Melenhorst, I.
    Barrett, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S181 - S181
  • [27] Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis
    Termeer, C
    Averbeck, M
    Hara, H
    Eibel, H
    Herrlich, P
    Sleeman, J
    Simon, JC
    IMMUNOLOGY, 2003, 109 (01) : 32 - 40
  • [28] Improved Strategy for Rapid Generation of Quadrivirus-Specific CD8+and CD4+Cytotoxic T Lymphocytes (CTLs) for Adoptive Transfer After Stem Cell Transplantation (SCT)
    Spyridonidis, Alexandros
    Muranski, Pawel
    Kerkar, Sid
    Tanimoto, Kazushi
    Hensel, Nancy F.
    Melenhorst, J. Joseph
    Barrett, A. John
    BLOOD, 2012, 120 (21)
  • [29] Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone
    SS Winter
    JM Greene
    TS McConnell
    CL Willman
    Leukemia, 1999, 13 : 2007 - 2011
  • [30] T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4+ cytotoxic T-cell clone, induced by a natural HIV type-1 variant peptide
    Bouhdoud, L
    Villain, P
    Merzouki, A
    Arella, M
    Couture, C
    JOURNAL OF VIROLOGY, 2000, 74 (05) : 2121 - 2130